Company

MedGenesis Therapeutix, Inc.

MedGenesis Therapeutix develops biopharmaceutical therapies for neurological and degenerative diseases.

About

MedGenesis Therapeutix develops biopharmaceutical therapies for chronic pain and neurodegenerative disorders. Its drug delivery systems are designed to target specific sites in the central nervous system. The company is based in Victoria, Canada, and is led by CEO Erich Mohr. It raised USD 5 mn on January 10, 2012.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in